Company news

Rani Therapeutics Holdings, Inc. news in 2026

Rani Therapeutics Holdings, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Rani Therapeutics Reports Third Quarter 2026 Financial Results; Provides Corporate Update

November 9, 2026

Rani Therapeutics to Participate in the Chardan Healthcare Conference

October 13, 2026

Rani Therapeutics Announces Acceptance into U.S. FDA's Emerging Technology Program (ETP)

October 5, 2026

Rani Therapeutics to Participate in Upcoming September Conferences

September 8, 2026

Rani Therapeutics Reports Second Quarter 2026 Financial Results; Provides Corporate Update

August 13, 2026

Rani Therapeutics Appoints Michelle Gilson to Board of Directors

August 4, 2026

Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

July 20, 2026

Rani Therapeutics Announces Positive Initial Phase 1a Data for RT-114 for the Treatment of Obesity, with Oral Bioavailability Exceeding Matched Subcutaneous Dosing

July 15, 2026

Rani Therapeutics Announces Research and Development Collaboration with PegBio to Expand Obesity Pipeline Across Multiple Novel Candidates

July 9, 2026

Rani Therapeutics Appoints Nicholas Maestas as Chief Financial Officer

June 29, 2026

Rani Therapeutics Holdings, Inc. Announces Pricing of $20.0 Million Registered Direct Offering of Class A Common Stock Priced At-The-Market Under Nasdaq Rules

May 26, 2026

Rani Therapeutics Reports First Quarter 2026 Financial Results; Provides Corporate Update; Announces CFO Transition

May 15, 2026

Rani Therapeutics to Participate in the H.C. Wainwright Annual BioConnect Investor Conference

May 12, 2026

Rani Therapeutics Appoints Dr. Sara Kenkare-Mitra as Strategic Advisor to Advance Platform and Clinical Strategy

April 8, 2026

Rani Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Corporate Update

March 25, 2026

Rani Therapeutics Appoints Jesper Høiland as Head of Strategy to Advance Corporate and Pipeline Prioritization

March 24, 2026

Rani Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results

March 19, 2026

Rani Therapeutics Announces the Promotion of Alireza Javadi, Ph.D. to Chief Technical Officer

January 28, 2026

Rani Therapeutics Initiates Phase 1 Study of RT-114 RaniPill® for the Treatment of Obesity in Collaboration with ProGen

January 8, 2026

Calls in 2026

Decks in 2026